UK firm signs deal to speed up development of cannabis-based drugs
Oxford Cannabinoid Technologies has signed a deal with drug development firm Evotec as it moves towards Phase 1 clinical trials
Oxford Cannabinoid Technologies has signed a deal with drug development firm Evotec as it moves towards Phase 1 clinical trials
Consumers spent $426 million on pet CBD products in 2020.
It’s been described as a “historic” moment for the sector.
Voyager Life launched its first fundraising round just eight months ago
It’s launched a nationwide call for researchers seeking medical cannabis for their studies.Â
It will be the first multi-brand CBD-focused consumer goods business to list on the LSE.
Construction on the purpose-built facility in Lincolnshire is expected to commence in July.
The MP has previously advocated for access to medical cannabis
Avida Global aims to become a vertically integrated seed to sales business
Cross-party MPs and peers have backed a campaign to end 50 years of ‘drug failure’ in the UK
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.